Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013:3:1990.
doi: 10.1038/srep01990.

Comparative population structure of Plasmodium falciparum circumsporozoite protein NANP repeat lengths in Lilongwe, Malawi

Affiliations
Comparative Study

Comparative population structure of Plasmodium falciparum circumsporozoite protein NANP repeat lengths in Lilongwe, Malawi

Natalie M Bowman et al. Sci Rep. 2013.

Abstract

Humoral immunity to Plasmodium falciparum circumsporozoite protein is partly mediated by a polymorphic NANP tetra-amino acid repeat. Antibody response to these repeats is the best correlate of protective immunity to the RTS,S malaria vaccine, but few descriptions of the natural variation of these repeats exist. Using capillary electrophoresis to determine the distribution of NANP repeat size polymorphisms among 98 isolates from Lilongwe, Malawi, we characterised the diversity of P. falciparum infection by several ecological indices. Infection by multiple distinct variants was common, and 20 distinct repeat sizes were identified. Diversity of P. falciparum appeared greater in children (18 variants) than adults (12 variants). There was evidence of genetic distance between different geographic regions by Nei's Standard Genetic Distance, suggesting parasite populations vary locally. We show that P. falciparum is very diverse with respect to NANP repeat length even on a local level and that diversity appears higher in children.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Distribution of variants based upon the number of NANP repeats in all participants, children, and adults.
The x-axis indicates the number of NANP repeats and the y-axis indicates the number of study participants with that variant detected in their blood.
Figure 2
Figure 2. Variant species accumulation and rarefaction curves with 95% confidence intervals.
Variant accumulation and rarefaction curves for all participants (a), adults (b), and children (c) are shown. Variant accumulation curves of the raw data are shown in dark blue. Computed smoothed rarefaction curves determined by simulation are shown as thick red lines, and 95% confidence intervals for the rarefaction curves are demonstrated by thin red lines. The computed rarefaction curve represents the expected average rate of variant accumulation that would be produced by repeated sampling of the same population.
Figure 3
Figure 3. Analysis of genetic similarity between different parts of the city of Lilongwe.
Panel A shows the geographic regions within and around Lilongwe used for the spatial analysis. Arrows show the pairwise comparison between each region and Nei's standard genetic distance between parasites identified in each population. The East Urban Region was the most diverse and had the highest number of participants (48 individuals, 61 variants), followed by the West Urban (25 individuals, 32 variants), West Peri-urban (10 individuals, 11 variants), and East Peri-urban (9 individuals, 11 variants). The map was prepared using ArcGIS (ESRI, Redlands, CA) and Microsoft Powerpoint (Microsoft, Seattle, WA). Panel B shows a principle coordinate analysis of genetic relatedness between regions. East and west urban regions cluster more closely to each other than either periurban region. Coordinate 1 explains 78.9% of the variation and coordinate 2 explains 18.8% of the variation.
Figure 4
Figure 4. Frequency distribution of specific NANP variants within each region.
The east urban region demonstrated the greatest diversity of parasites, but it also had the largest number of samples. As seen in the figure, the distribution of individual variants differed by geographic region.

References

    1. World Health Organization. World Malaria Report 2012. WHO Publications: Geneva, (2012).
    1. RTS,S Clinical Trials Partnership. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. New Engl J Med. 365, 1863–1875 (2011). - PubMed
    1. RTS,S Clinical Trials Partnership. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. New Engl J Med. 367, 2284–2295 (2012). - PMC - PubMed
    1. Olutu A., Fegan G. & Wambua J. et al. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. New Engl J Med. 368, 1111–1120 (2013). - PMC - PubMed
    1. Calvo-Calle J. M. et al. Immunogenecity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum. J Immunol. 150, 1403–1412 (1993). - PubMed

Publication types

Substances

LinkOut - more resources